1WD9
Calcium bound form of human peptidylarginine deiminase type4 (PAD4)
1WD9 の概要
エントリーDOI | 10.2210/pdb1wd9/pdb |
関連するPDBエントリー | 1WD8 1WDA |
分子名称 | Protein-arginine deiminase type IV, CALCIUM ION, SULFATE ION, ... (4 entities in total) |
機能のキーワード | post-translational enzyme, hydrolase |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Cytoplasm: Q9UM07 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 75274.26 |
構造登録者 | Arita, K.,Hashimoto, H.,Shimizu, T.,Nakashima, K.,Yamada, M.,Sato, M. (登録日: 2004-05-12, 公開日: 2004-07-13, 最終更新日: 2024-05-29) |
主引用文献 | Arita, K.,Hashimoto, H.,Shimizu, T.,Nakashima, K.,Yamada, M.,Sato, M. Structural basis for Ca(2+)-induced activation of human PAD4 Nat.Struct.Mol.Biol., 11:777-783, 2004 Cited by PubMed Abstract: Peptidylarginine deiminase 4 (PAD4) is a Ca(2+)-dependent enzyme that catalyzes the conversion of protein arginine residues to citrulline. Its gene is a susceptibility locus for rheumatoid arthritis. Here we present the crystal structure of Ca(2+)-free wild-type PAD4, which shows that the polypeptide chain adopts an elongated fold in which the N-terminal domain forms two immunoglobulin-like subdomains, and the C-terminal domain forms an alpha/beta propeller structure. Five Ca(2+)-binding sites, none of which adopt an EF-hand motif, were identified in the structure of a Ca(2+)-bound inactive mutant with and without bound substrate. These structural data indicate that Ca(2+) binding induces conformational changes that generate the active site cleft. Our findings identify a novel mechanism for enzyme activation by Ca(2+) ions, and are important for understanding the mechanism of protein citrullination and for developing PAD-inhibiting drugs for the treatment of rheumatoid arthritis. PubMed: 15247907DOI: 10.1038/nsmb799 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.6 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード